Research
AMKR
The Scorecard: 1 Month Update: AMKR Sell — Correct so far
Revisiting our Sell call on AMKR: entry $60.71, latest $51.74, -14.8%.
The Scorecard: AMKR Sell — Correct so far
Revisiting our Sell call on AMKR: entry $60.71, latest $51.74, -14.8%.
Amkor Technology Stock Analysis: AMKR Free Cash Flow, Valuation & Customer Concentration
Amkor Technology (AMKR) is rated Sell as valuation remains rich while free cash flow is still negative. Customer concentration and heavy capex leave less room…
Most Popular Research
EOSEHOLDEos Energy Enterprises Stock Analysis: EOSE Cash Burn, Revenue Growth & Financing RiskEos Energy Enterprises (EOSE) earns a Sell rating as rapid Q1 revenue growth is offset by persistent cash…CASYMade IN USA (USDW) 10-K: Risk Factors Changes Lead 22 June 2026 Filing RoundupMade IN USA (USDW)'s Risk Factors section changed the most among 14 companies that filed 10-Ks on 22…SOUNSELLSoundHound AI Stock Analysis: Valuation, Cash Burn, Margins & Customer RiskSoundHound AI (SOUN) is rated SELL as rapid revenue growth is offset by weak profitability and ongoing cash…USACHOLDUSA Compression Partners Stock Analysis: Buy or Sell? Leverage, Distribution Risk & Cash FlowUSA Compression Partners, LP (USAC) is rated Hold as its fixed-fee compression franchise supports steadier cash flow, but…BSXBUYBoston Scientific Stock Analysis: Valuation, Reimbursement Risk, Cash Flow & GrowthBoston Scientific (BSX) earns a Buy rating on double-digit revenue growth, expanding EBITDA, and improving free cash flow.…PATHHOLDUiPath Stock Analysis: Valuation, ARR Growth, Retention & Free Cash FlowUiPath (PATH) earns a HOLD rating as its valuation already reflects a better monetization and margin story. ARR…